Skip to main content
Premium Trial:

Request an Annual Quote

DuPont Listeria Assay Gets AOAC Certification

NEW YORK (GenomeWeb News) —DuPont said today that its BAX System real-time PCR assay for Listeria species has been certified by the AOAC Research Institute as a Performance Tested Method.

The assay has been validated on frankfurters, cooked shrimp, spinach, queso fresco, and environmental surfaces using reference method media as well as proprietary media for a shorter, single-stage enrichment, DuPont said.

The AOAC Research Institute, a subsidiary of AOAC International in Rockville, Md., validated the BAX System method as equivalent to the reference culture method for detecting Listeria species, but with much faster time to results, the company added.

BAX System assays for detecting Escherichia coli O157:H7, non-O157 STEC, Campylobacter and other pathogens are already PTM-certified. In addition, AOAC International has awarded Official Method of Analysis status to the system for detecting Salmonella and L. monocytogenes, and DuPont noted that these assays can be run in conjunction with the Listeria species test.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.